-+ 0.00%
-+ 0.00%
-+ 0.00%

COMPASS THERAPEUTICS: $180 MLN IN CASH AND MARKETABLE SECURITIES AT END OF Q2 2026, WHICH IS EXPECTED TO FUND OPERATIONS INTO 2028

Reuters·08/06/2026 11:30:02

Please log in to view news